Arcutis Biotherapeutics, Inc. (ARQT)
25.16
-0.13
(-0.51%)
USD |
NASDAQ |
Oct 02, 16:00
25.16
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Market Cap : 3.160B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 3.160B |
| October 01, 2026 | 3.176B |
| September 30, 2026 | 3.319B |
| September 29, 2026 | 3.360B |
| September 28, 2026 | 3.432B |
| September 25, 2026 | 3.381B |
| September 24, 2026 | 3.299B |
| September 23, 2026 | 3.313B |
| September 22, 2026 | 3.489B |
| September 21, 2026 | 3.260B |
| September 18, 2026 | 3.187B |
| September 17, 2026 | 3.323B |
| September 16, 2026 | 3.283B |
| September 15, 2026 | 2.953B |
| September 14, 2026 | 3.048B |
| September 11, 2026 | 3.000B |
| September 10, 2026 | 2.936B |
| September 09, 2026 | 2.994B |
| September 08, 2026 | 3.063B |
| September 04, 2026 | 3.002B |
| September 03, 2026 | 2.971B |
| September 02, 2026 | 2.995B |
| September 01, 2026 | 2.983B |
| August 31, 2026 | 3.010B |
| August 28, 2026 | 2.987B |
| Date | Value |
|---|---|
| August 27, 2026 | 3.123B |
| August 26, 2026 | 3.157B |
| August 25, 2026 | 3.122B |
| August 24, 2026 | 3.112B |
| August 21, 2026 | 3.150B |
| August 20, 2026 | 3.184B |
| August 19, 2026 | 3.323B |
| August 18, 2026 | 3.333B |
| August 17, 2026 | 3.216B |
| August 14, 2026 | 3.289B |
| August 13, 2026 | 3.244B |
| August 12, 2026 | 3.301B |
| August 11, 2026 | 3.294B |
| August 10, 2026 | 3.255B |
| August 07, 2026 | 3.176B |
| August 06, 2026 | 3.319B |
| August 05, 2026 | 3.404B |
| August 04, 2026 | 3.269B |
| August 03, 2026 | 3.258B |
| July 31, 2026 | 3.359B |
| July 30, 2026 | 3.500B |
| July 29, 2026 | 3.484B |
| July 28, 2026 | 3.554B |
| July 27, 2026 | 3.481B |
| July 24, 2026 | 3.420B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Insmed, Inc. | 24.26B |
| Emergent BioSolutions, Inc. | 324.73M |
| Exelixis, Inc. | 14.53B |
| Puma Biotechnology, Inc. | 485.99M |
Market Cap Related Metrics
| PE Ratio | 121.49 |
| PS Ratio | 7.236 |
| Price to Book Value | 14.33 |
| Price to Free Cash Flow | 85.76 |
| Price | 25.16 |
| Earnings Yield | 0.82% |
| Operating PE Ratio | 98.02 |
| Normalized PE Ratio | 121.25 |